Company / Current Liabilities per Share
Q32 Bio Inc. Current Liabilities per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.93
FY2025
5-year range
$0.20 / $45.79
FY2021-FY2025
Trend
-98.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 8 years, ranging from $0.20 in FY2023 to $45.79 in FY2024.
Based on SEC 10-K filings.
0.93 in FY2025 with a 5-year CAGR of +13.1%.
Increased from $0.20 to $0.93 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +33.0%
- 5-Year CAGR
- +13.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 98.0% year-over-year.
- Peak current liabilities per share was recorded in FY2024.
- Lowest current liabilities per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.93 | -98.0% |
| FY2024 | $45.79 | +22644.7% |
| FY2023 | $0.20 | -49.0% |
| FY2022 | $0.40 | +15.3% |
| FY2021 | $0.34 | -31.8% |
| FY2020 | $0.50 | +51.6% |
| FY2019 | $0.33 | -96.6% |
| FY2018 | $9.64 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026